National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 23975-23976 [2021-09490]
Download as PDF
23975
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: Generic
Clearance to Collect Stakeholder
Feedback on the Research Domain
Criteria (RDoC) Initiative, 0925–0756,
EXTENSION, exp., date 07/31/2021,
National Institute of Mental Health
(NIMH), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This request serves as notice
that the National Institute of Mental
Health (NIMH) plans to collect
rdoc/index.shtml), and several
educational and training resources
(including webinars) to educate the field
and interface with scientists who may
have questions about RDoC (https://
www.nimh.nih.gov/research-priorities/
rdoc/rdoc-educational-and-trainingresources.shtml). The evaluation
approach will be conducted using
surveys centered around current content
(i.e., website, twitter, and webinars), as
well as open ended surveys that will
cover the scientific content of RDoC.
The information collected will be used
by NIMH staff to determine success of
the RDoC initiative, develop future
directions and endeavors, and to help
guide programmatic priorities for RDoC
and the Institute.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
490.
stakeholder feedback to assess the
strengths and weaknesses of the
Research Domain Criteria (RDoC)
initiative. NIMH launched RDoC in
2009 to implement Strategy 1.4 of the
2008 NIMH Strategic Plan: ‘‘Develop
new ways of classifying disorders based
on dimensions of observable behaviors
and brain functions.’’ Rather than
beginning with a syndrome and then
working ‘‘down’’ to clarify mechanisms,
the aim of RDoC is to guide research
that begins with disruptions in
neurobiological and behavioral
mechanisms, and then works across
systems to clarify connections among
such disruptions and clinical
symptoms. NIMH has developed social
media platforms and tools for the RDoC
initiative, including a dedicated RDoC
twitter account (https://twitter.com/
nimh_rdoc), the RDoC website, which
also houses the RDoC matrix (https://
www.nimh.nih.gov/research-priorities/
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Instrument type
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden hours
Workshops .......................................................................................................
Interviews .........................................................................................................
Surveys ............................................................................................................
Focus Groups ..................................................................................................
Evaluation Forms .............................................................................................
50
10
100
10
100
1
1
1
1
1
8
30/60
30/60
1
15/60
400
5
50
10
25
Total ..........................................................................................................
270
270
........................
490
Dated: April 14, 2021.
Andrew A. Hooper,
Project Clearance Liaison, National Institute
of Mental Health, National Institutes of
Health.
[FR Doc. 2021–09486 Filed 5–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
D–SEP.
Date: June 29–July 1, 2021.
Time: 09:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3398, hayesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Dated: April 30, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09492 Filed 5–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\05MYN1.SGM
05MYN1
23976
Federal Register / Vol. 86, No. 85 / Wednesday, May 5, 2021 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; R13 Conference
Grant Applications.
Date: June 24, 2021.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, National
Institutes of Health, Room 7011, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, yangj@
extra.niddk.nih.gov,
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 30, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–09490 Filed 5–4–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[Docket No. FWS–R2–ES–2020–0133;
FXES11130200000–212–FF02ENEH00]
Endangered and Threatened Wildlife
and Plants; Initiation of 5-Year Status
Reviews of 23 Species in the
Southwest
AGENCY:
Fish and Wildlife Service,
Interior.
Common name
Scientific name
Notice of initiation of reviews;
request for information.
ACTION:
We, the U.S. Fish and
Wildlife Service, are conducting 5-year
status reviews under the Endangered
Species Act of 23 animal and plant
species. A 5-year status review is based
on the best scientific and commercial
data available at the time of the review;
therefore, we are requesting submission
of any such information that has become
available since the last review for the
species.
DATES: To ensure consideration, we are
requesting submission of new
information no later than June 4, 2021.
However, we will continue to accept
new information about any listed
species at any time.
ADDRESSES: For how to request or
submit information, see Request for
Information and How Do I Ask
Questions or Provide Information? in
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: For
general information, please contact
Angela Anders, via phone at 505–248–
7953 or via email at Angela_Anders@
fws.gov (email). For information on a
particular species, contact the
appropriate person or office listed in the
table in the SUPPLEMENTARY INFORMATION
section. Individuals who are hearing
impaired or speech impaired may call
the Federal Relay Service at 800–877–
8339 for TTY assistance.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Why do we conduct a 5-year review?
Under the Endangered Species Act of
1973, as amended (ESA; 16 U.S.C. 1531
et seq.), we maintain Lists of
Endangered and Threatened Wildlife
and Plants (which we collectively refer
to as the List) in the Code of Federal
Regulations (CFR) at 50 CFR 17.11 (for
animals) and 17.12 (for plants). Section
4(c)(2)(A) of the ESA requires us to
review each listed species’ status at least
Listing status
Final listing rule
(Federal Register
citation and
publication date)
Current range
once every 5 years. Our regulations at 50
CFR 424.21 require that we publish a
notice in the Federal Register
announcing those species under active
review. For additional information
about 5-year reviews, refer to our
factsheet at https://www.fws.gov/
endangered/what-we-do/recoveryoverview.html.
What information do we consider in
our review?
A 5-year review considers all new
information available at the time of the
review. In conducting these reviews, we
consider the best scientific and
commercial data that have become
available since the listing determination
or most recent status review, such as:
(A) Species biology, including but not
limited to population trends,
distribution, abundance, demographics,
and genetics;
(B) Habitat conditions, including but
not limited to amount, distribution, and
suitability;
(C) Conservation measures that have
been implemented that benefit the
species;
(D) Threat status and trends in
relation to the five listing factors (as
defined in section 4(a)(1) of the ESA);
and
(E) Other new information, data, or
corrections, including but not limited to
taxonomic or nomenclatural changes,
identification of erroneous information
contained in the List, and improved
analytical methods.
Any new information will be
considered during the 5-year review and
will also be useful in evaluating the
ongoing recovery programs for the
species.
Which species are under review?
The species in the following table are
under active 5-year status review.
Contact person, phone,
email
Contact person’s U.S.
mail address
U.S. Fish and Wildlife
Service, Arizona Ecological Services Office, 9828 North 31st
Avenue, #C3, Phoenix, AZ 85051–2518.
U.S. Fish and Wildlife
Service, Southwest
Regional Office, P.O.
Box 1306, Albuquerque, NM, 87103.
ANIMALS
Trout, Apache .....
Oncorhynchus
apache.
Threatened ......
Arizona (USA) ...............
40 FR 29863, 7/16/1975
Jeff Humphrey, Field
Supervisor, 602–242–
0210 (phone) or
Jeff_Humphrey@
fws.gov (email).
Crane, whooping
Grus americana ....
Endangered .....
Kansas, Montana, Nebraska, North Dakota,
Oklahoma, South Dakota, Texas, Wisconsin (USA), and
Canada.
32 FR 4001, 3/11/1967
Peter Fasbender, Assistant Regional Director—Ecological
Services, 505–248–
6671 (office phone) or
Peter_Fasbender@
fws.gov (email).
VerDate Sep<11>2014
23:06 May 04, 2021
Jkt 253001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 86, Number 85 (Wednesday, May 5, 2021)]
[Notices]
[Pages 23975-23976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 23976]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; R13 Conference Grant
Applications.
Date: June 24, 2021.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Yang, Ph.D., Scientific Review Officer,
Review Branch, Division of Extramural Activities, NIDDK, National
Institutes of Health, Room 7011, 6707 Democracy Boulevard, Bethesda,
MD 20892-5452, (301) 594-7799, [email protected],
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: April 30, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-09490 Filed 5-4-21; 8:45 am]
BILLING CODE 4140-01-P